InvestorsHub Logo
Followers 144
Posts 27709
Boards Moderated 3
Alias Born 02/07/2004

Re: TechKim post# 51

Friday, 02/19/2016 3:56:29 AM

Friday, February 19, 2016 3:56:29 AM

Post# of 651

Like getting a loan without interest



LOL, not quite so, but an interesting comparison
nevertheless.

smile smile smile

The PR says:

The non-dilutive grants are repayable from royalties generated from future sales of BiondVax's vaccine, once
available on the market.



Of course i have no idea of the details however
there is an agreement which enables NATI to
provide funds in return to getting royalties.
Naturally if the vaccine proves a flop, NATI gets
absolutely nothing in return.

If however the vaccine does generate income, the royalties
are in % of sales for a set amount of (quite many)
years, thus enabling NATI to assist/invest in other
potential projects!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y